NOVO-PENTOBARB 100MG 100 MG — DIN 00020990
PENTOBARBITAL SODIUM : 100 MG · NOVOPHARM LIMITED · CAPSULE · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is NOVO-PENTOBARB 100MG?
NOVO-PENTOBARB 100MG 100 MG contains PENTOBARBITAL SODIUM : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 00020990, held by NOVOPHARM LIMITED, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Aug-2005. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Pentobarbital in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
4 holders have a Canadian DIN containing Pentobarbital, across 6 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| ABBOTT LABORATORIES, LIMITED | 2 | 0 | NEMBUTAL SODIUM CAP 100MG, NEMBUTAL SODIUM INJ 50MG/ML | No marketed DIN |
| SABEX INC | 2 | 0 | NOVA RECTAL SUP 25MG, NOVA RECTAL SUP 50MG | No marketed DIN |
| NOVOPHARM LIMITED | 1 | 0 | NOVO-PENTOBARB 100MG | No marketed DIN |
| SANDS PHARM | 1 | 0 | PENTOBARBITAL SODIUM CAP 50MG | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Pentobarbital |
|---|---|
| ATC code | N05CA01 |
| AHFS class | 28:24.04 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00020990 |
|---|---|
| DIN (unpadded, as printed on some documents) | 20990 |
| Brand name | NOVO-PENTOBARB 100MG |
| Generic / active ingredient | PENTOBARBITAL SODIUM : 100 MG |
| Market authorization holder | NOVOPHARM LIMITED |
| Health Canada schedule | CONTROLLED DRUGS (CDSA IV) |
| ATC code | N05CA01 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N05CA |
| Current status | CANCELLED POST MARKET |
| Status date | 10-Aug-2005 |
| Original market date | 1967-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 6 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| NEMBUTAL SODIUM CAP 100MG | 100 MG | CAPSULE | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | 00000086 |
| NEMBUTAL SODIUM INJ 50MG/ML | 50 MG | SOLUTION | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | 00000213 |
| NOVA RECTAL SUP 25MG | 25 MG | SUPPOSITORY | SABEX INC | CANCELLED POST MARKET | 00606502 |
| NOVA RECTAL SUP 50MG | 50 MG | SUPPOSITORY | SABEX INC | CANCELLED POST MARKET | 00606510 |
| PENTOBARBITAL SODIUM CAP 50MG | 50 MG | CAPSULE | SANDS PHARM | CANCELLED POST MARKET | 00233994 |
2 · Same class — other molecules in ATC N05CA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Pentobarbital | NEMBUTAL SODIUM CAP 100MG · NEMBUTAL SODIUM INJ 50MG/ML · NOVA RECTAL SUP 25MG · NOVA RECTAL SUP 50MG · +2 more | 6 | 0 | Not in Canada |
| Amobarbital | AMYTAL SODIUM 500MG · AMYTAL SODIUM CAP 60MG · AMYTAL SODIUM PULVULE 222 0.2GM | 3 | 0 | Not in Canada |
| Barbiturates, Plain | BUTISOL SODIUM TAB 100MG · BUTISOL SODIUM TAB 15MG · BUTISOL SODIUM TAB 30MG | 3 | 0 | Not in Canada |
| Secobarbital | NOVO-SECOBARB 100MG · SECONAL SODIUM PULVULE 240 0.1GM | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N05C
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N05CF | Eszopiclone · Zaleplon · Zolpidem · Zopiclone | 125 | 57 |
| N05CD | Estazolam · Flurazepam · Midazolam · Nitrazepam · Temazepam · +1 more | 108 | 21 |
| N05CM | Dexmedetomidine · Ethchlorvynol · Scopolamine · Valerianae Radix | 31 | 11 |
| N05CC | Chloral Hydrate · Paraldehyde | 9 | 1 |
| N05CJ | Daridorexant · Suvorexant | 6 | 1 |
| N05CB | Combinations Of Barbiturates | 2 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is NOVO-PENTOBARB 100MG called?
The same molecule, Pentobarbital, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Euthasol Dechra | Latin | Iceland |
| Euthasol vet. | Latin | Iceland |
| Exagon vet. | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.